Investor Relations

SEC Filings

  o View CEL-SCI's SEC Filings  
       

Corporate Overview

  o View Corporate Overview  
       

CEL-SCI Presentations & Interviews

  June 5, 2018
Listen to Geert Kersten at the 8th Annual LD Micro Invitational

 
  May 9, 2018
Geert Kersten's Presentation from The NYC Oncology Investor Conference 2018

 
  May 8, 2018
Geert Kersten's Presentation from The 2018 Disruptive Growth & Healthcare Conference

 
  April 10, 2018
Geert Kersten's Presentation from The Microcap Conference

 
  February 13, 2018
Geert Kersten at the 2018 BIO CEO & Investor Conference

 
  September 11, 2017
Geert Kersten at the Rodman & Renshaw 19th Annual Global Investment Conference

 
  February 2016
Geert Kersten as a featured guest on Fox Business' Making Money with Charles Payne

 
  January 2016
Interview with Dr. Eyal Talor, Chief Scientific Officer

 

Warrant Quote

  o NYSE American: CVM WS  

 

Press Releases

  o All Press Releases  
 
  JULY 13, 2018
NEW STORY CEL-SCI Reports on NYSE American Noncompliance Notice and Compliance Plan
  JULY 9, 2018
NEW STORY CEL-SCI Corporation Issues Letter to Shareholders
  JULY 2, 2018
NEW STORY CEL-SCI Announces the Closing of Its $5 Million Registered Direct Offering
  JUNE 27, 2018
NEW STORY CEL-SCI Receives $2.1 Million from Warrant Exercises
  JUNE 27, 2018
NEW STORY CEL-SCI Wins Breach of Contract Ruling Against Clinical Research Organization inVentiv, Now Known as Syneos Health
  JUNE 11, 2018
NEW STORY CEL-SCI Corporation Issues Letter to Shareholders
  JUNE 8, 2018
NEW STORY U.S. Patent Office Allows New CEL-SCI Patents for LEAPS Vaccine Platform Technology
   

Gavin de Windt
Phone: +1 703-506-9460
E-mail: gdewindt@cel-sci.com